A broad look into the future of rheumatoid arthritis

Despite all improvements in rheumatoid arthritis, we are still not able to prevent or cure the disease. Diagnostic delays due to lack of access to a specialist and costly therapies are still a major obstacle for many patients. Even in first-world countries, the treat-to-target principle and the goal...

Full description

Saved in:
Bibliographic Details
Published inTherapeutic Advances in Musculoskeletal Disease Vol. 14; p. 1759720X221076211
Main Authors Mucke, Johanna, Krusche, Martin, Burmester, Gerd R.
Format Book Review Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.02.2022
SAGE PUBLICATIONS, INC
SAGE Publishing
Subjects
A Glance Into the Future of Rheumatology
Medical research
Musculoskeletal diseases
Precision medicine
Rheumatoid arthritis
digital health
Rheumatoid arthritis
P4 medicine
personalized medicine
Online AccessGet full text

Cover

More Information
Summary:Despite all improvements in rheumatoid arthritis, we are still not able to prevent or cure the disease. Diagnostic delays due to lack of access to a specialist and costly therapies are still a major obstacle for many patients. Even in first-world countries, the treat-to-target principle and the goal of disease remission are often missed. Thus, rheumatoid arthritis (RA) is still the reason for disability and reduced quality of life for many patients. So, is it time to move the goalpost even further? Where are we heading next? And will we finally be able to cure the disease? These questions are addressed in our review article.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Johanna Mucke and Martin Krusche share the first authorship.
ISSN:1759-720X
1759-7218
DOI:10.1177/1759720X221076211